A Real-World Data Observational Analysis of the Impact of Liposomal Amphotericin B on Renal Function Using Machine Learning in Critically Ill Patients
Background: Liposomal amphotericin B (L-AmB) has become the mainstay of treatment for severe invasive fungal infections. However, the potential for renal toxicity must be considered. Aims: To evaluate the incidence of acute kidney injury (AKI) in critically ill patients receiving L-AmB for more than...
Saved in:
Main Authors: | Ignasi Sacanella (Author), Erika Esteve-Pitarch (Author), Jessica Guevara-Chaux (Author), Julen Berrueta (Author), Alejandro García-Martínez (Author), Josep Gómez (Author), Cecilia Casarino (Author), Florencia Alés (Author), Laura Canadell (Author), Ignacio Martín-Loeches (Author), Santiago Grau (Author), Francisco Javier Candel (Author), María Bodí (Author), Alejandro Rodríguez (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Machine Learning Approach to Determine Risk Factors for Respiratory Bacterial/Fungal Coinfection in Critically Ill Patients with Influenza and SARS-CoV-2 Infection: A Spanish Perspective
by: Alejandro Rodríguez, et al.
Published: (2024) -
Single-dose liposomal amphotericin B for visceral leishmaniasis
by: Nilima A Kshirsagar
Published: (2014) -
Different liposomal amphotericin B formulations for visceral leishmaniasis
by: Thomas P C Dorlo, et al.
Published: (2014) -
Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.
by: Gloria Morizot, et al.
Published: (2016) -
Different liposomal amphotericin B formulations for visceral leishmaniasis-Author's reply
by: Nilima Kshirsagar
Published: (2014)